Congress closes loophole funneling billions to failing Caribbean medical schools

What it does

This bill eliminates special exemptions that have allowed three for-profit Caribbean medical schools to receive federal student loan funding without meeting the same accountability standards required of other foreign medical schools. It requires all foreign medical schools to meet consistent eligibility criteria—including minimum pass rates on medical licensing exams and limits on the percentage of non-U.S. citizens enrolled—and phases out federal funding for schools that fail to comply, though students already enrolled get a grace period to finish their degrees.

Why we flagged it

The bill's core function is to eliminate a grandfather exemption that has allowed three for-profit Caribbean medical schools to bypass standard eligibility requirements for federal student loan participation. It is fundamentally a subsidy-equity measure, not a new program or broad deregulation.

What the text implies

• The grace period (up to 4 years post-enactment for enrolled students) may create a temporary surge in enrollment at affected schools as students rush to lock in federal loan eligibility before the deadline, potentially inflating short-term debt burdens.
• Affected schools may respond by raising tuition or reducing admissions standards to maximize revenue during the grace period, potentially harming the students the bill aims to protect.
• The bill does not address whether the Department of Education will actively monitor or enforce the new eligibility criteria, leaving implementation risk unclear.
• Residency match rates and attrition data cited in findings suggest foreign graduates from these schools face significant career barriers; the bill does not address whether students will be informed of these disparities before enrollment.

Who it affects

Ordinary taxpayers and prospective medical students benefit from eliminating a subsidy carve-out that has funneled three-quarters of foreign medical school federal aid to three for-profit institutions with dramatically higher failure and attrition rates (30% vs. 3.2% at U.S. schools) and worse residency match outcomes. Closing this loophole protects federal dollars and reduces the risk that students will accumulate debt at schools with poor track records.

Who stands to gain

• U.S. taxpayers (reduced federal loan subsidy to underperforming institutions)
• U.S. and osteopathic medical schools (reduced competition for residency positions from lower-perform

Named in the bill

Caribbean for-profit medical schools, Department of Education, National Committee on Foreign Medical Education and Accreditation, Educational Commission for Foreign Medical Graduates, Higher Education Act of 1965, Title IV federal student loan programs

Where it stands

• Feb 2, 2026 — Introduced · Congress.gov: “Introduced in Senate”
• Feb 2, 2026 — Referred to Senate Committee on Health, Education, Labor, and Pensions · Congress.gov: “Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S443)”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

2 lobbying clients named this bill on 2 disclosure filings across 1 quarter, Jun 2026 to Jun 2026. Those filings disclosed $961,438 in lobbying spend. A filing names 25 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 41% of bills with at least one filing.

Richard Durbin, the sponsor, reported $-29,800 in PAC receipts in the 2026 cycle.

• Association of American Medical Colleges — $821,438 on 1 filing
• American Association of Colleges of Osteopathic Medicine — $140,000 on 1 filing

Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.